Anti-human-cytomegalovirus immunoglobulin G levels in glioma risk and prognosis

Consensus on the role of human cytomegalovirus in glioblastoma

(2012) K. Dziurzynski et al.   NEURO-ONCOLOGY

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009

(2012) T. A. Dolecek et al.   NEURO-ONCOLOGY

Human immunoglobulin G levels of viruses and associated glioma risk

(2011) Sara Sjöström et al.   CANCER CAUSES & CONTROL

Genetic and Viral Etiology of Glioblastoma--a Unifying Hypothesis

(2011) J. P. Pandey   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

National Prevalence Estimates for Cytomegalovirus IgM and IgG Avidity and Association between High IgM Antibody Titer and Low IgG Avidity

(2011) Sheila C. Dollard et al.   Clinical and Vaccine Immunology

The roles of viruses in brain tumor initiation and oncomodulation

(2011) Alexander Kofman et al.   JOURNAL OF NEURO-ONCOLOGY

Inherited predisposition to glioma

(2011) A. P. Kyritsis et al.   NEURO-ONCOLOGY

Role of Type 1 IFNs in Antiglioma Immunosurveillance--Using Mouse Studies to Guide Examination of Novel Prognostic Markers in Humans

(2010) M. Fujita et al.   CLINICAL CANCER RESEARCH

Effects of antihistamine and anti-inflammatory medication use on risk of specific glioma histologies

(2010) Michael E. Scheurer et al.   INTERNATIONAL JOURNAL OF CANCER

Molecular epidemiology of primary brain tumors

(2009) Jun Gu et al.   Neurotherapeutics

Long-term Anti-inflammatory and Antihistamine Medication Use and Adult Glioma Risk

(2008) M. E. Scheurer et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION